C-myc Gene Amplification in Colorectal Cancer
Author Information
Author(s): L Masramon, R Arribas, S T6rtola, M Perucho, MA Peinado
Primary Institution: Institut de Recerca Oncologica, Hospital Duran i Reynals
Hypothesis
Is there a relationship between c-myc gene amplification and molecular and clinicopathological variables in colorectal carcinomas?
Conclusion
C-myc gene amplification occurs in about 26% of colorectal cancer cases and is associated with more advanced tumor stages and mutations in the p53 gene.
Supporting Evidence
- C-myc amplification was found in 26% of colorectal cancer cases analyzed.
- The incidence of c-myc amplification was higher in advanced Dukes' stages.
- C-myc amplification was associated with mutations in the p53 tumor-suppressor gene.
Takeaway
This study found that a gene called c-myc is often more active in colorectal cancer, especially in more serious cases.
Methodology
The study used a DNA fingerprinting method called targeted arbitrarily primed PCR (TAP-PCR) to analyze c-myc gene amplification in colorectal carcinoma samples.
Limitations
The study's findings may be affected by the presence of non-tumor cells in the samples, which could mask the true degree of amplification.
Statistical Information
P-Value
0.048
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website